/

QDEL

QuidelOrtho CorporationAfter hours

14.10+0.85 +6.42%USD

NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 14.10 0.00%

Open

13.40

Prev close

13.25

Day range

13.3314.61

52-week range

9.9235.58

Volume

3.05M1.94×

Mkt cap

966.91M

P/E ttm

—

Fwd P/E

9.78

EPS ttm

-15.39

Div yield

0.00%

Earnings

Aug 6, 2026

From 52w high

−60.37%

Price Chart

Yahoo Finance · delayed

QDELOct 13, 2026O 13.40H 14.61L 13.33C 14.10+0.85 (+6.42%)Vol 3.05M

SMA 5013.06
SMA 20017.42

1Y change −46.53% since Oct 10, 2025 close540 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

QDEL QuidelOrtho Corporation · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +12.17%
1 month: +19.69%
3 months: −20.16%
6 months: −18.59%
Year to date: −50.63%
1 year: −46.41%

Valuation & ownership

Market cap: 966.91M
Enterprise value: 3.86B
P/E (ttm): —
Forward P/E: 9.78
PEG ratio: 2.06
Price / book: 0.54
Price / sales (ttm): 0.36
EV / EBITDA: 7.97
EPS (ttm): -15.39
EPS (forward): 1.44
Beta (5y monthly): 0.78
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 68.58M
Float: 61.17M
Short % of float: 29.73%
Short ratio (days): 11.10
Held by insiders: 0.90%
Held by institutions: 124.27%
Avg volume (3m): 1.57M
50-day average: 13.13
200-day average: 17.49
52-week change: −46.41%
S&P 500 52-week: +17.50%

Technicals (daily)

RSI (14): 65.4
vs 50-day SMA: +7.99%
vs 200-day SMA: −19.05%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 6.10%
Realised vol (20d, ann.): 65.8%
From 52-week high: −60.37%
From 52-week low: +42.14%

ANR

Analyst Consensus

3 analysts

Consensus

—

Mean target

14.67

+4.02% implied

Low 12.00Median 12.00High 20.00

Recommendation trend

Now1 / 1 / 1
1m ago1 / 1 /

DES

About QuidelOrtho Corporation

Yahoo Finance profile

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.

Sector: Healthcare
Industry: Medical Devices
Employees: 6,500
Headquarters

SEAS

Seasonality · QDEL

2007–2026 · monthly returns

Strongest month Jul +5.35%Weakest month Feb −4.40%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-4.9	-16.3	-27.7	-25.1	5.9	34.6	-4.3	-14.0	-27.0	33.8			−50.6%
2025	-2.4	-8.0	-12.6	-20.5	10.4	-6.0	-20.1	24.6	2.6	-8.4	1.3	4.4	−35.9%
2024	-7.0	-33.4	5.1	-15.4	9.0	-24.8	18.3	7.5	7.9	-16.6	7.8	8.7	−39.6%
2023	-0.1	1.6	2.5	1.0	-5.3	-2.7	5.4	-5.7	-11.3	-16.4	12.5	7.2	−14.0%
2022	-23.4	2.4	6.3	-10.5	-5.6	2.3	5.0	-22.3	-9.8	25.7	-2.5	-2.2	−36.5%
2021	39.7	-34.5	-22.1	-18.1	12.7	8.5	10.4	-8.8	9.5	-5.9	11.1	-8.5	−24.9%
2020	2.4	0.6	26.6	42.1	25.9	27.9	26.2	-37.7	24.7	22.3	-27.3	-7.9	+139.4%
2019	18.9	13.0	-0.1	-2.3	-13.5	7.3	-0.5	6.8	-2.7	-7.3	20.6	9.3	+53.7%
2018	5.6	-4.7	18.8	9.4	10.6	6.1	2.0	13.3	-15.2	-1.2	-5.5	-19.7	+12.6%
2017	-11.4	10.6	7.8	6.8	2.7	9.3	17.9	9.2	25.5	-6.6	-7.2	14.1	+102.4%
2016	-19.6	-8.0	10.1	0.2	-4.0	7.5	27.7	-4.5	1.5	-12.6	18.8	-6.6	+1.0%
2015	-18.6	9.1	5.1	-13.6	-7.0	5.9	-9.8	-0.6	-8.3	1.8	12.9	-2.3	−26.7%
2014	-4.3	-5.2	-2.6	-21.4	5.8	-2.6	8.0	-1.1	13.9	6.3	-2.4	3.8	−6.4%
2013	20.2	5.5	0.3	-6.0	7.1	6.8	4.9	-0.9	7.1	-13.2	2.0	22.8	+65.5%
2012	-5.5	-0.8	29.5	-10.1	-4.8	-0.3	-0.1	3.6	16.6	-7.4	0.0	6.5	+23.4%
2011	-6.0	-3.1	-9.1	11.0	15.6	-1.2	-1.3	2.1	7.1	9.1	1.6	-16.6	+4.7%
2010	-3.6	-1.7	11.3	1.5	-20.7	8.5	-2.3	-2.5	-9.1	5.1	14.4	9.4	+4.9%
2009	-5.9	-10.2	-16.5	26.2	9.2	14.6	2.5	3.4	5.1	-11.9	-12.1	9.6	+5.4%
2008	-19.0	4.2	-2.3	-0.3	6.6	-3.1	22.5	-3.5	-16.1	-3.7	-13.8	-4.1	−32.9%
2007	-0.2	-20.8	11.4	16.5	5.2	19.5	-15.3	14.1	15.2	5.6	-8.5	3.0	+43.0%

INSD

Insider Activity · QDEL

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Aug 13, 2026	Hanson Bryan MichaelOfficer	—	446	—
Jun 30, 2026	Hanson Bryan MichaelOfficer	—	5.8K	—
Jun 4, 2026	Polan Mary Lake Ph.DDirector	Stock Award(Grant) at price 0.00 per share.	973	—
Jun 4, 2026	Widder Kenneth Jon M.D.Director	Stock Award(Grant) at price 0.00 per share.	1.2K	—
Jun 4, 2026	Michael Edward LDirector	Stock Award(Grant) at price 0.00 per share.	1.3K	—
Jun 4, 2026	Buechler Kenneth FDirector	Stock Award(Grant) at price 0.00 per share.	2.2K	—
Jun 4, 2026	Polan Mary Lake Ph.DDirector	Conversion of Exercise of derivative security at price 14.33 per share.	749	$10.73K
Jun 4, 2026	Buechler Kenneth FDirector	Conversion of Exercise of derivative security at price 14.33 per share.	1.7K	$23.77K
Jun 4, 2026	Widder Kenneth Jon M.D.Director	Conversion of Exercise of derivative security at price 14.33 per share.	910	$13.04K
Jun 4, 2026	Michael Edward LDirector	Conversion of Exercise of derivative security at price 14.33 per share.	963	$13.80K
May 28, 2026	Wilkins Joseph D JrDirector	Stock Award(Grant) at price 0.00 per share.	6.8K	—
May 28, 2026	Chiminski John RDirector	Stock Award(Grant) at price 0.00 per share.	6.8K	—
May 28, 2026	Polan Mary Lake Ph.DDirector	Stock Award(Grant) at price 0.00 per share.	6.8K	—
May 28, 2026	Widder Kenneth Jon M.D.Director	Stock Award(Grant) at price 0.00 per share.	6.8K	—
May 28, 2026	Strobeck MatthewDirector	Stock Award(Grant) at price 0.00 per share.	6.8K	—
May 28, 2026	Michael Edward LDirector	Stock Award(Grant) at price 0.00 per share.	6.8K	—
May 28, 2026	Buechler Kenneth FDirector	Stock Award(Grant) at price 0.00 per share.	6.8K	—
May 28, 2026	Dilsaver Evelyn SDirector	Stock Award(Grant) at price 0.00 per share.	6.8K	—
May 28, 2026	Rhoads Ann DDirector	Stock Award(Grant) at price 0.00 per share.	6.8K	—
May 28, 2026	Huennekens R ScottDirector	Stock Award(Grant) at price 0.00 per share.	6.8K	—

QDEL

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

QDEL

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About QuidelOrtho Corporation

Seasonality · QDEL

Insider Activity · QDEL

Congress Trades · QDEL

Investors Holding QDEL

Investors Holding QDEL

Congress Trades · QDEL

Insider Activity · QDEL

Seasonality · QDEL

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About QuidelOrtho Corporation

Financial Snapshot

Earnings & Dividends

News